Transfusion practice in coronary artery bypass surgery in Denmark: A multicenter audit

Interactive Cardiovascular and Thoracic Surgery

Volumn 6, Issue 5, 2007, Pages 623-627

  Andreasen, Jan J ^a   Westen, Mikkel ^b   Pallesen, Peter A ^c   Jensen, Søren ^d   Gorst Rasmussen, Anders ^a   Johnsen, Søren P ^a,e  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood loss; Coronary artery bypass grafting; Transfusion

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN;

AGED; ANASTOMOSIS; ANESTHESIST; ARTERY CLAMP; ARTICLE; BLOOD; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DENMARK; DRUG USE; EDUCATION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL PRACTICE; MEDICAL RECORD; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURGEON; TIME; BLEEDING; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; EVALUATION; HEALTH CARE QUALITY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; STANDARD; STATISTICS;

AGED; ANASTOMOSIS, SURGICAL; ANTIFIBRINOLYTIC AGENTS; BLOOD COMPONENT TRANSFUSION; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DENMARK; FEMALE; HEMOGLOBINS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS;

EID: 34848872763     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2007.154401     Document Type: Article

References (14)

1. Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia 2004;8:267-281.
2. Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, Fabri BM, Rashid A. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 2005;27:592-598.
3. Légaré J-F, Buth KJ, King S, Wood J, Sullivan JA, Friesen CH, Lee J, Stewart K, Hirsch GM. Coronary bypass surgery performed off-pump does not result in lower in-hospital morbidity than coronary artery grafting performed on pump. Circulation 2004;109:887-892.
4. Kytölä L, Nuutinen L, Myllylä G. Transfusion policies in coronary artery bypass - a nationwide survey in Finland. Acta Anaesthesiol Scand 1998;42:178-183.
5. Stover EP, Siegel LC, Parks R, Parks R, Levin J, Body SC, Maddi R, D'Ambra MN, Mangano DT, Spiess BD, the Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines. A 24-institution study. Anesthesiology 1998;88:327-333.
6. Goodnough LT, Johnston MFM, Ramsey G, Sayers MH, Eisenstadt RS, Anderson KC, Rutman RC, Silberstein LE. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 1990;50:675-683.
7. Toy PTCY. Effectiveness of transfusion audits and practice guidelines. Arch Pathol Lab Med 1994;118:435-437.
8. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R, the EuroSCORE study group. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
9. Hongo RH, Ley J, Dick SE, Yee RR. The effects of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002;40:231-237.
10. Engelberger L, Faeh B, Berdat PA, Eberli F, Meier B, Carrel T. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 2004;26:96-101.
11. Fox KAA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome. The Clopidogrel in Unstable angina to Prevent Recurrent ischemic Events (CURE) trial. Circulation 2004;110:1202-1208.
12. Kapetanakis EI, Medlam DA, Boyce SW, Haile E, Hill PC, Dullum MKC, Bafi AS, Petro KR, Corso PJ. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 2005;26:576-583.
13. Cannon CP, Mehta SR, Aranki SF. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Ann Thorac Surg 2005;80:768-779.
14. Raja SG, Dreyfus GD. Impact of off-pump coronary artery bypass surgery on postoperative bleeding: current best available evidence. J Card Surg 2006;21:35-41.